Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08189 TEDA BIOMEDICAL
RT Nominal unchange0.430 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others59,013-5.868%62,69273,62778,76279,573
Land & other Lease Assets38,8869.041%35,66239,30953,28659,237
Intangible Assets0--0012,07437
Interests in Asso. & JCEs0--0000
Other Non-current Assets1800.000%180000

98,079-0.461%98,533112,936144,122138,847
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Inventories83,98711.525%75,30890,45774,00475,221
Trade Receivables34,218216.287%10,8198,77731,86732,082
Cash & Bank Balances52,271105.790%25,4005,9346,85626,439
Other Current Assets146,61019.713%122,46770,42080,34770,058
Assets Held for Sale0--014,75404,948

317,08535.510%233,994190,342193,075208,749
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Trade Payables33,084270.412%8,93216,10720,72329,533
S-T Debt & Leases87,034-36.113%136,23156,66967,37245,131
Other Current Liabilities167,25524.909%133,902133,991130,154117,360
Liab asso w/ Assets Held for Sale0--010,07600

287,3732.977%279,065216,842218,249192,024
Net Current Assets29,712--(45,071)(26,500)(25,175)16,725
Total Assets Less Current Liabilities127,791139.031%53,46286,436118,947155,572
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
L-T Debt & Leases25,5477.866%23,68420,29535,23445,212
Other Non-current Liabilities1,3380.000%1,3381,5612,5640

26,8857.445%25,02221,85637,79745,212
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
  Share Capital213,39012.637%189,450189,450189,450189,450
  Reserves(116,772)-30.203%(167,301)(139,499)(119,339)(88,669)
  Others0--0000
Shareholders' Funds96,618336.218%22,14949,95170,111100,781
Non-controlling Interests4,288-31.845%6,29114,62811,0399,579
Others0--0000

100,906254.803%28,44064,57981,150110,359
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Commitments----008002,403
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 22/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -6,426
%Change55.860%
EPS / (LPS)RMB -0.003
NBV Per Share (¥)RMB 0.045
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.